
Marsha M. Tsay
Examiner (ID: 332, Phone: (571)272-2938 , Office: P/1656 )
| Most Active Art Unit | 1656 |
| Art Unit(s) | 1656, 1653 |
| Total Applications | 1124 |
| Issued Applications | 471 |
| Pending Applications | 130 |
| Abandoned Applications | 543 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10620603
[patent_doc_number] => 09339530
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-17
[patent_title] => 'Process for separating proteins fibrinogen, factor XIII and biological glue from a solubilized plasma fraction and for preparing lyophilised concentrates of said proteins'
[patent_app_type] => utility
[patent_app_number] => 14/056886
[patent_app_country] => US
[patent_app_date] => 2013-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4863
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14056886
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/056886 | Process for separating proteins fibrinogen, factor XIII and biological glue from a solubilized plasma fraction and for preparing lyophilised concentrates of said proteins | Oct 16, 2013 | Issued |
Array
(
[id] => 10422854
[patent_doc_number] => 20150307865
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-29
[patent_title] => 'COAGULATION FACTOR VII POLYPEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 14/675887
[patent_app_country] => US
[patent_app_date] => 2013-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 24841
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14675887
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/675887 | COAGULATION FACTOR VII POLYPEPTIDES | Oct 14, 2013 | Abandoned |
Array
(
[id] => 9330079
[patent_doc_number] => 20140056861
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-27
[patent_title] => 'RECOMBINANT FACTOR VIII HAVING INCREASED STABILITY'
[patent_app_type] => utility
[patent_app_number] => 14/052452
[patent_app_country] => US
[patent_app_date] => 2013-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 20996
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14052452
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/052452 | RECOMBINANT FACTOR VIII HAVING INCREASED STABILITY | Oct 10, 2013 | Abandoned |
Array
(
[id] => 12388398
[patent_doc_number] => 09963707
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-08
[patent_title] => Multiprotein expression cassettes
[patent_app_type] => utility
[patent_app_number] => 14/433113
[patent_app_country] => US
[patent_app_date] => 2013-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 27
[patent_no_of_words] => 20913
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 264
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14433113
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/433113 | Multiprotein expression cassettes | Oct 2, 2013 | Issued |
Array
(
[id] => 10355242
[patent_doc_number] => 20150240247
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-27
[patent_title] => 'TROPHIC CONVERSION OF PHOTOAUTOTROPHIC BACTERIA FOR IMPROVED DIURNAL PROPERTIES'
[patent_app_type] => utility
[patent_app_number] => 14/431751
[patent_app_country] => US
[patent_app_date] => 2013-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 25745
[patent_no_of_claims] => 70
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14431751
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/431751 | TROPHIC CONVERSION OF PHOTOAUTOTROPHIC BACTERIA FOR IMPROVED DIURNAL PROPERTIES | Sep 26, 2013 | Abandoned |
Array
(
[id] => 9538698
[patent_doc_number] => 20140163345
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-12
[patent_title] => 'IMPLANTABLE BIOSENSOR AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/034218
[patent_app_country] => US
[patent_app_date] => 2013-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 19157
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14034218
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/034218 | Implantable biosensor and methods of use thereof | Sep 22, 2013 | Issued |
Array
(
[id] => 10347825
[patent_doc_number] => 20150232830
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-20
[patent_title] => 'GENE, MICROBE, CONVERSION METHOD, AND MANUFACTURING METHOD'
[patent_app_type] => utility
[patent_app_number] => 14/429459
[patent_app_country] => US
[patent_app_date] => 2013-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7754
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14429459
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/429459 | GENE, MICROBE, CONVERSION METHOD, AND MANUFACTURING METHOD | Sep 18, 2013 | Abandoned |
Array
(
[id] => 10347890
[patent_doc_number] => 20150232896
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-20
[patent_title] => 'ISOLATED GENES AND TRANSGENIC ORGANISMS FOR PRODUCING BIOFUELS'
[patent_app_type] => utility
[patent_app_number] => 14/429287
[patent_app_country] => US
[patent_app_date] => 2013-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 12255
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14429287
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/429287 | Isolated genes and transgenic organisms for producing biofuels | Sep 17, 2013 | Issued |
Array
(
[id] => 9222567
[patent_doc_number] => 20140017342
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-16
[patent_title] => 'NITRITE AND NITRITE-METHEME THERAPY TO DETOXIFY STROMA-FREE HEMOGLOBIN BASED BLOOD SUBSTITUTES'
[patent_app_type] => utility
[patent_app_number] => 14/028850
[patent_app_country] => US
[patent_app_date] => 2013-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 40
[patent_no_of_words] => 30234
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14028850
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/028850 | NITRITE AND NITRITE-METHEME THERAPY TO DETOXIFY STROMA-FREE HEMOGLOBIN BASED BLOOD SUBSTITUTES | Sep 16, 2013 | Abandoned |
Array
(
[id] => 10452014
[patent_doc_number] => 20150337028
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-26
[patent_title] => 'Double Mutant Coagulation Factor VIII and Methods Thereof'
[patent_app_type] => utility
[patent_app_number] => 14/427936
[patent_app_country] => US
[patent_app_date] => 2013-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10254
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14427936
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/427936 | Double Mutant Coagulation Factor VIII and Methods Thereof | Sep 11, 2013 | Abandoned |
Array
(
[id] => 9174463
[patent_doc_number] => 20130316448
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-28
[patent_title] => 'PEPTIDES AND RELATED MOLECULES THAT MODULATE NERVE GROWTH FACTOR ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 13/957916
[patent_app_country] => US
[patent_app_date] => 2013-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 24584
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 33
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13957916
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/957916 | PEPTIDES AND RELATED MOLECULES THAT MODULATE NERVE GROWTH FACTOR ACTIVITY | Aug 1, 2013 | Abandoned |
Array
(
[id] => 10381921
[patent_doc_number] => 20150266927
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-24
[patent_title] => 'HIGH EFFICIENCY METHOD FOR PURIFYING HUMAN PAPILLOMAVIRUS VIRUS-LIKE PARTICLES'
[patent_app_type] => utility
[patent_app_number] => 14/418004
[patent_app_country] => US
[patent_app_date] => 2013-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 15581
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14418004
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/418004 | High efficiency method for purifying human papillomavirus virus-like particles | Jul 29, 2013 | Issued |
Array
(
[id] => 11250547
[patent_doc_number] => 09476037
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-10-25
[patent_title] => 'Factor VII polypeptides that are modified and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 13/987492
[patent_app_country] => US
[patent_app_date] => 2013-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 111322
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13987492
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/987492 | Factor VII polypeptides that are modified and uses thereof | Jul 29, 2013 | Issued |
Array
(
[id] => 9537281
[patent_doc_number] => 20140161928
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-12
[patent_title] => 'Preparation for Use of Aspartate for Regulating Glucose Levels in Blood'
[patent_app_type] => utility
[patent_app_number] => 13/941625
[patent_app_country] => US
[patent_app_date] => 2013-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16052
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13941625
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/941625 | Preparation for use of aspartate for regulating glucose levels in blood | Jul 14, 2013 | Issued |
Array
(
[id] => 10262796
[patent_doc_number] => 20150147793
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-28
[patent_title] => 'METHOD FOR THE PREPARATION OF 2,4-DIHYDROXYBUTYRATE'
[patent_app_type] => utility
[patent_app_number] => 14/414331
[patent_app_country] => US
[patent_app_date] => 2013-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 13356
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14414331
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/414331 | Method for the preparation of 2,4-dihydroxybutyrate | Jul 9, 2013 | Issued |
Array
(
[id] => 10305482
[patent_doc_number] => 20150190482
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-09
[patent_title] => 'PLASMINOGEN ACTIVATOR MUTANTS AS ANTIFIBRINOLYTIC AGENTS'
[patent_app_type] => utility
[patent_app_number] => 14/412873
[patent_app_country] => US
[patent_app_date] => 2013-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 21187
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14412873
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/412873 | Plasminogen activator mutants as anti-fibrinolytic agents | Jul 1, 2013 | Issued |
Array
(
[id] => 9212564
[patent_doc_number] => 20140011741
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-09
[patent_title] => 'HEMOGLOBIN COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 13/924283
[patent_app_country] => US
[patent_app_date] => 2013-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 31950
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13924283
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/924283 | Hemoglobin compositions | Jun 20, 2013 | Issued |
Array
(
[id] => 10354923
[patent_doc_number] => 20150239929
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-27
[patent_title] => 'METHOD FOR PURIFICATION OF RECOMBINANT FACTOR XA DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 14/406645
[patent_app_country] => US
[patent_app_date] => 2013-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 7617
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14406645
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/406645 | METHOD FOR PURIFICATION OF RECOMBINANT FACTOR XA DERIVATIVES | Jun 11, 2013 | Abandoned |
Array
(
[id] => 10468896
[patent_doc_number] => 20150353911
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-10
[patent_title] => 'CHIMERIC CLOTTING FACTORS'
[patent_app_type] => utility
[patent_app_number] => 14/406160
[patent_app_country] => US
[patent_app_date] => 2013-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 50298
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14406160
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/406160 | Chimeric clotting factors | Jun 6, 2013 | Issued |
Array
(
[id] => 10299144
[patent_doc_number] => 20150184142
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-02
[patent_title] => 'PROCOAGULANT COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 14/406163
[patent_app_country] => US
[patent_app_date] => 2013-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 45623
[patent_no_of_claims] => 113
[patent_no_of_ind_claims] => 42
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14406163
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/406163 | Procoagulant compounds | Jun 6, 2013 | Issued |